Diltiazem Hydrochloride
NDC Package 68151-2113-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Diltiazem Hydrochloride is diltiazem is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree AV block except in the presence of a functioning ventricular pacemaker, (3) patients with severe hypotension (less than 90 mm Hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission. Marketed by Carilion Materials Management, this product is identified by NDC 68151-2113 and is authorized under FDA application NDA020401.

Identification & Billing

NDC Package Code
68151-2113-9
Package Description
1 CAPSULE, EXTENDED RELEASE in 1 PACKAGE
Product Code
68151-2113
11-Digit Billing Format
68151211309
RxNorm Crosswalk
  • RxCUI: 830837 - dilTIAZem HCl 240 MG 24HR Extended Release Oral Capsule
  • RxCUI: 830837 - 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule
  • RxCUI: 830837 - diltiazem HCl 240 MG 24 HR Extended Release Oral Capsule

Clinical Specifications

Proprietary Name
Diltiazem Hydrochloride
Dosage Form
-
Usage Information
Diltiazem is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree AV block except in the presence of a functioning ventricular pacemaker, (3) patients with severe hypotension (less than 90 mm Hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.

Regulatory & Marketing

Labeler Name
Carilion Materials Management
FDA Application #
NDA020401
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
09-25-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68151-2113-9 identifies a specific commercial package of 1 capsule, extended release in 1 package of Diltiazem Hydrochloride, labeled by Carilion Materials Management. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carilion Materials Management on September 25, 2009. The current certification is valid through December 31, 2017.

How is this Carilion Materials Management product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68151211309. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68151-2113-9
11-Digit CMS (5-4-2)
68151-2113-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.